Citation Impact
Citing Papers
Recent Molecular Genetic Explorations of Caenorhabditis elegans MicroRNAs
2018 StandoutNobel
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells
2003
Superinfection Exclusion in Cells Infected with Hepatitis C Virus
2007 StandoutNobel
The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis
2006
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
2013
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
2006 Standout
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells
2009
Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex
2001 StandoutNobel
Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate
2003
agriGO: a GO analysis toolkit for the agricultural community
2010 Standout
Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma
1998
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus
1999
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
MicroRNA sponges: Progress and possibilities
2010
Head and neck cancer
2008 Standout
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression
2014
cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation
2016
Effect of Mechanical Ventilation on Inflammatory Mediators in Patients With Acute Respiratory Distress Syndrome
1999 Standout
Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications
2009
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
2011 Standout
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists
2007 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Global mapping of miRNA-target interactions in cattle (Bos taurus)
2017 StandoutNobel
Newcastle disease virus (NDV): brief history of its oncolytic strains
2000
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
2020
Expression of Drug Resistance‐related Genes in Head and Neck Squamous Cell Carcinoma and Normal Mucosa
2000
CLASSIFICATION AND STAGING OF MELANOMA
1998
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
Emerging Biological Principles of Metastasis
2017 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Activation-Induced Cytidine Deaminase Expression in CD4+ T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age
2011 StandoutNobel
Interleukin-2 and interleukin-15: immunotherapy for cancer
2002
A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience
2003
Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR
1999
Stable knockdown of microRNA in vivo by lentiviral vectors
2008
Interleukin-2: Clinical applications
2002
Argonaute CLIP-Seq reveals miRNA targetome diversity across tissue types
2014
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Alternative activation of macrophages
2003 Standout
MicroRNA
2017 Standout
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
High-Level Transduction and Gene Expression in Hematopoietic Repopulating Cells Using a Human Imunodeficiency Virus Type 1-Based Lentiviral Vector Containing an Internal Spleen Focus Forming Virus Promoter
2002
Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells
2004 StandoutNobel
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
2007 StandoutNobel
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
2013
Augmented IL-15Rα Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice
2012 StandoutNobel
Viruses and Apoptosis
1999
Soluble receptors in human disease
1998
Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells
1997
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Zanvil Alexander Cohn 1926-1993.
1994 StandoutNobel
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Cytokine Storm
2020 Standout
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Prognostic Significance of Occult Metastases Detected by Sentinel Lymphadenectomy and Reverse Transcriptase–Polymerase Chain Reaction in Early-Stage Melanoma Patients
1999
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
Importance of IL-10 for CTLA-4-Mediated Inhibition of Tumor-Eradicating Immunity
2004
Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines
2008
Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.
1993
Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal Cancer
2003
Adoptive T cell therapy using antigen-specific CD8+T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cells
2002
Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment
2007
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
International Staging System for Multiple Myeloma
2005 Standout
Works of Iris Dallmann being referenced
Interleukin-12 Inhibits Apoptosis in Chronic Lymphatic Leukemia (CLL) B Cells
2002
Predictive Impact of Retinoid X Receptor-Alpha-Expression in Renal-Cell Carcinoma
2004
Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma
1999
Peripheral Blood Tyrosinase Messenger RNA Detection and Survival in Malignant Melanoma
1996
Induction of Cytokines and Cytotoxicity against Tumor Cells by Newcastle Disease Virus
1994
Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cells
1994
Immunocytochemical Detection of P-Glycoprotein: Initial Expression Correlates with Survival in Renal Cell Carcinoma Patients
1994
Lentivirus-mediated antagomir expression for specific inhibition of miRNA function
2007
Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study.
1990
Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypes.
1991
Cytostatic drug sensitivity test for human multiple myeloma, measuring monoclonal immunoglobulin produced by bone marrow cells in vitro
1986
In vivo and ex vivo antitumor activity in patients receiving low-dose subcutaneous recombinant interleukin-2.
1992
Enforced expression of miR-125b affects myelopoiesis by targeting multiple signaling pathways
2011
Inhibition of GM-CSF Receptor Function by Stable RNA Interference in a NOD/SCID Mouse Hematopoietic Stem Cell Transplantation Model
2003